VivoSeq
Other

Anesthesia

5

Pipeline Programs

27

Active Trials

7

Companies Involved

Anesthesia is an early-stage landscape with 5 programs across 7 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Eisai, Fresenius Kabi Oncology Ltd.. 2 therapies are approved.

Pipeline Metrics

Competitive Density

44/100

Pipeline Velocity

42/100

Mech. Concentration

25/100

Completion Rate

85/100

Attrition Rate

11/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

159

clinical trials

Completed93 · 58%
Unknown status22 · 14%
Recruiting13 · 8%
Terminated10 · 6%
Not yet recruiting9 · 6%
Withdrawn7 · 4%
Other5 · 3%

Trial Activity

159 trials

Desflurane vs. Propofol for Cardiac Anesthesia
Recruiting·XXijing Hospital·Phase 3·NCT07116733·3,560 enrolled
Minimal Flow Anesthesia and Infection Risk
Active, not recruiting··N/A·NCT07092046·140 enrolled
Page 1 of 11

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)